avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Cpeb1
|
ENSMUSG00000025586.10 | cytoplasmic polyadenylation element binding protein 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Cpeb1 | mm10_v2_chr7_-_81454751_81454764 | 0.14 | 4.3e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr19_-_44407703 | 5.00 |
ENSMUST00000041331.2
|
Scd1
|
stearoyl-Coenzyme A desaturase 1 |
chr19_+_39287074 | 3.91 |
ENSMUST00000003137.8
|
Cyp2c29
|
cytochrome P450, family 2, subfamily c, polypeptide 29 |
chr19_-_20727533 | 3.53 |
ENSMUST00000025656.3
|
Aldh1a7
|
aldehyde dehydrogenase family 1, subfamily A7 |
chr7_-_30924169 | 3.28 |
ENSMUST00000074671.6
|
Hamp2
|
hepcidin antimicrobial peptide 2 |
chr4_+_60838256 | 3.09 |
ENSMUST00000098035.4
|
Gm21286
|
predicted gene, 21286 |
chr19_-_39463067 | 2.96 |
ENSMUST00000035488.2
|
Cyp2c38
|
cytochrome P450, family 2, subfamily c, polypeptide 38 |
chr19_+_44203265 | 2.88 |
ENSMUST00000026220.5
|
Scd3
|
stearoyl-coenzyme A desaturase 3 |
chr9_-_48605147 | 2.67 |
ENSMUST00000034808.5
ENSMUST00000119426.1 |
Nnmt
|
nicotinamide N-methyltransferase |
chr3_+_14863495 | 2.60 |
ENSMUST00000029076.4
|
Car3
|
carbonic anhydrase 3 |
chr17_+_79626669 | 2.53 |
ENSMUST00000086570.1
|
4921513D11Rik
|
RIKEN cDNA 4921513D11 gene |
chr19_+_39007019 | 2.48 |
ENSMUST00000025966.4
|
Cyp2c55
|
cytochrome P450, family 2, subfamily c, polypeptide 55 |
chr5_-_87254804 | 2.46 |
ENSMUST00000075858.3
|
Ugt2b37
|
UDP glucuronosyltransferase 2 family, polypeptide B37 |
chr18_-_74961252 | 2.34 |
ENSMUST00000066532.4
|
Lipg
|
lipase, endothelial |
chr8_-_5105232 | 2.21 |
ENSMUST00000023835.1
|
Slc10a2
|
solute carrier family 10, member 2 |
chr19_+_58670358 | 2.18 |
ENSMUST00000057270.7
|
Pnlip
|
pancreatic lipase |
chr19_+_40089688 | 2.16 |
ENSMUST00000068094.6
ENSMUST00000080171.2 |
Cyp2c50
|
cytochrome P450, family 2, subfamily c, polypeptide 50 |
chr19_+_39510844 | 2.10 |
ENSMUST00000025968.4
|
Cyp2c39
|
cytochrome P450, family 2, subfamily c, polypeptide 39 |
chr5_-_87591582 | 1.86 |
ENSMUST00000031201.7
|
Sult1e1
|
sulfotransferase family 1E, member 1 |
chr11_-_78422217 | 1.71 |
ENSMUST00000001122.5
|
Slc13a2
|
solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 |
chr11_-_113710017 | 1.68 |
ENSMUST00000018871.1
|
Cpsf4l
|
cleavage and polyadenylation specific factor 4-like |
chrX_-_165004829 | 1.56 |
ENSMUST00000114890.2
|
Gm17604
|
predicted gene, 17604 |
chr13_+_49582745 | 1.53 |
ENSMUST00000065494.7
|
Omd
|
osteomodulin |
chr19_-_42612766 | 1.52 |
ENSMUST00000166128.1
ENSMUST00000026190.7 ENSMUST00000164786.1 |
Loxl4
|
lysyl oxidase-like 4 |
chr14_+_37068042 | 1.51 |
ENSMUST00000057176.3
|
Lrit2
|
leucine-rich repeat, immunoglobulin-like and transmembrane domains 2 |
chr2_+_69670100 | 1.48 |
ENSMUST00000100050.3
|
Klhl41
|
kelch-like 41 |
chr9_+_7445822 | 1.47 |
ENSMUST00000034497.6
|
Mmp3
|
matrix metallopeptidase 3 |
chr9_+_55326913 | 1.38 |
ENSMUST00000085754.3
ENSMUST00000034862.4 |
AI118078
|
expressed sequence AI118078 |
chrX_+_139563316 | 1.31 |
ENSMUST00000113027.1
|
Rnf128
|
ring finger protein 128 |
chrX_+_10252305 | 1.25 |
ENSMUST00000049910.6
|
Otc
|
ornithine transcarbamylase |
chr19_+_55741810 | 1.24 |
ENSMUST00000111657.3
ENSMUST00000061496.9 ENSMUST00000041717.7 ENSMUST00000111662.4 |
Tcf7l2
|
transcription factor 7 like 2, T cell specific, HMG box |
chr7_+_6474088 | 1.19 |
ENSMUST00000056144.5
|
Olfr1346
|
olfactory receptor 1346 |
chr6_+_79818031 | 1.18 |
ENSMUST00000179797.1
|
Gm20594
|
predicted gene, 20594 |
chr18_+_20247340 | 1.18 |
ENSMUST00000054128.6
|
Dsg1c
|
desmoglein 1 gamma |
chr8_+_45658666 | 1.16 |
ENSMUST00000134675.1
ENSMUST00000139869.1 ENSMUST00000126067.1 |
Sorbs2
|
sorbin and SH3 domain containing 2 |
chr15_+_44196135 | 1.13 |
ENSMUST00000038856.6
ENSMUST00000110289.3 |
Trhr
|
thyrotropin releasing hormone receptor |
chr6_-_28126125 | 1.13 |
ENSMUST00000115324.2
ENSMUST00000090512.3 |
Grm8
|
glutamate receptor, metabotropic 8 |
chr6_-_85333412 | 1.11 |
ENSMUST00000059034.6
ENSMUST00000045846.5 ENSMUST00000113788.1 |
Sfxn5
|
sideroflexin 5 |
chr3_-_93015669 | 1.09 |
ENSMUST00000107301.1
ENSMUST00000029521.4 |
Crct1
|
cysteine-rich C-terminal 1 |
chr2_+_58567360 | 1.09 |
ENSMUST00000071543.5
|
Upp2
|
uridine phosphorylase 2 |
chr17_+_43953191 | 1.08 |
ENSMUST00000044792.4
|
Rcan2
|
regulator of calcineurin 2 |
chr6_-_136804414 | 1.08 |
ENSMUST00000179285.1
|
Hist4h4
|
histone cluster 4, H4 |
chr18_-_61036189 | 1.05 |
ENSMUST00000025521.8
|
Cdx1
|
caudal type homeobox 1 |
chr1_-_193264006 | 1.05 |
ENSMUST00000161737.1
|
Hsd11b1
|
hydroxysteroid 11-beta dehydrogenase 1 |
chr3_+_5218546 | 1.03 |
ENSMUST00000026284.6
|
Zfhx4
|
zinc finger homeodomain 4 |
chr2_+_130576170 | 1.01 |
ENSMUST00000028764.5
|
Oxt
|
oxytocin |
chr8_+_34115030 | 1.01 |
ENSMUST00000095345.3
|
Mboat4
|
membrane bound O-acyltransferase domain containing 4 |
chr16_-_36990449 | 1.00 |
ENSMUST00000075869.6
|
Fbxo40
|
F-box protein 40 |
chr2_+_109692436 | 0.99 |
ENSMUST00000111050.3
|
Bdnf
|
brain derived neurotrophic factor |
chr13_+_93304940 | 0.98 |
ENSMUST00000109497.1
ENSMUST00000109498.1 ENSMUST00000060490.4 ENSMUST00000109492.1 ENSMUST00000109496.1 ENSMUST00000109495.1 |
Homer1
|
homer homolog 1 (Drosophila) |
chr17_-_91092715 | 0.98 |
ENSMUST00000160800.2
ENSMUST00000159778.1 ENSMUST00000160844.3 |
Nrxn1
|
neurexin I |
chr15_-_101940255 | 0.96 |
ENSMUST00000023799.7
|
Krt79
|
keratin 79 |
chr11_+_67238017 | 0.95 |
ENSMUST00000018632.4
|
Myh4
|
myosin, heavy polypeptide 4, skeletal muscle |
chr16_-_57754707 | 0.93 |
ENSMUST00000089332.4
|
Col8a1
|
collagen, type VIII, alpha 1 |
chr10_-_116896879 | 0.92 |
ENSMUST00000048229.7
|
Myrfl
|
myelin regulatory factor-like |
chr13_+_93304799 | 0.91 |
ENSMUST00000080127.5
|
Homer1
|
homer homolog 1 (Drosophila) |
chr1_+_180101144 | 0.90 |
ENSMUST00000133890.1
|
Cdc42bpa
|
CDC42 binding protein kinase alpha |
chr5_+_92386879 | 0.90 |
ENSMUST00000128246.1
|
Art3
|
ADP-ribosyltransferase 3 |
chr5_+_92392585 | 0.89 |
ENSMUST00000126281.1
|
Art3
|
ADP-ribosyltransferase 3 |
chrX_-_8193387 | 0.87 |
ENSMUST00000143223.1
ENSMUST00000033509.8 |
Ebp
|
phenylalkylamine Ca2+ antagonist (emopamil) binding protein |
chr2_-_51149100 | 0.86 |
ENSMUST00000154545.1
ENSMUST00000017288.2 |
Rnd3
|
Rho family GTPase 3 |
chr3_+_129532386 | 0.86 |
ENSMUST00000071402.2
|
Elovl6
|
ELOVL family member 6, elongation of long chain fatty acids (yeast) |
chr2_-_77519565 | 0.86 |
ENSMUST00000111830.2
|
Zfp385b
|
zinc finger protein 385B |
chr3_+_132085281 | 0.86 |
ENSMUST00000029665.5
|
Dkk2
|
dickkopf homolog 2 (Xenopus laevis) |
chr12_-_99393010 | 0.85 |
ENSMUST00000177451.1
|
Foxn3
|
forkhead box N3 |
chr1_+_167598450 | 0.84 |
ENSMUST00000111386.1
ENSMUST00000111384.1 |
Rxrg
|
retinoid X receptor gamma |
chr12_+_84569762 | 0.84 |
ENSMUST00000021665.5
ENSMUST00000169934.2 |
Vsx2
|
visual system homeobox 2 |
chr1_+_177444653 | 0.83 |
ENSMUST00000094276.3
|
Zbtb18
|
zinc finger and BTB domain containing 18 |
chr15_-_50890396 | 0.83 |
ENSMUST00000185183.1
|
Trps1
|
trichorhinophalangeal syndrome I (human) |
chr1_-_66945019 | 0.82 |
ENSMUST00000027151.5
|
Myl1
|
myosin, light polypeptide 1 |
chr13_+_23684192 | 0.82 |
ENSMUST00000018246.4
|
Hist1h2bc
|
histone cluster 1, H2bc |
chr1_-_58695944 | 0.82 |
ENSMUST00000055313.7
|
Als2cr12
|
amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 12 (human) |
chr18_+_20376723 | 0.81 |
ENSMUST00000076737.6
|
Dsg1b
|
desmoglein 1 beta |
chr8_+_45658731 | 0.81 |
ENSMUST00000143820.1
ENSMUST00000132139.1 |
Sorbs2
|
sorbin and SH3 domain containing 2 |
chr7_-_19421326 | 0.80 |
ENSMUST00000047020.1
|
A930016O22Rik
|
RIKEN cDNA A930016O22 gene |
chr1_+_153874335 | 0.80 |
ENSMUST00000055314.3
|
Gm5531
|
predicted gene 5531 |
chr3_+_90062781 | 0.80 |
ENSMUST00000029551.2
|
1700094D03Rik
|
RIKEN cDNA 1700094D03 gene |
chr2_-_77703252 | 0.80 |
ENSMUST00000171063.1
|
Zfp385b
|
zinc finger protein 385B |
chr18_+_20310738 | 0.80 |
ENSMUST00000077146.3
|
Dsg1a
|
desmoglein 1 alpha |
chr1_+_167598384 | 0.79 |
ENSMUST00000015987.3
|
Rxrg
|
retinoid X receptor gamma |
chr7_+_43690418 | 0.79 |
ENSMUST00000056329.6
|
Klk14
|
kallikrein related-peptidase 14 |
chr8_-_64205970 | 0.79 |
ENSMUST00000066166.4
|
Tll1
|
tolloid-like |
chr16_-_55838827 | 0.78 |
ENSMUST00000096026.2
ENSMUST00000036273.6 ENSMUST00000114457.1 |
Nfkbiz
|
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, zeta |
chr11_+_96282529 | 0.78 |
ENSMUST00000125410.1
|
Hoxb8
|
homeobox B8 |
chr19_+_39060998 | 0.78 |
ENSMUST00000087236.4
|
Cyp2c65
|
cytochrome P450, family 2, subfamily c, polypeptide 65 |
chr3_-_92458715 | 0.78 |
ENSMUST00000058142.3
|
Sprr3
|
small proline-rich protein 3 |
chr2_+_14174513 | 0.78 |
ENSMUST00000077517.7
|
Tmem236
|
transmembrane protein 236 |
chr11_+_29130733 | 0.77 |
ENSMUST00000020756.8
|
Pnpt1
|
polyribonucleotide nucleotidyltransferase 1 |
chr5_-_66150898 | 0.76 |
ENSMUST00000113725.1
ENSMUST00000094757.2 |
Rbm47
|
RNA binding motif protein 47 |
chr2_+_116900152 | 0.76 |
ENSMUST00000126467.1
ENSMUST00000128305.1 ENSMUST00000155323.1 |
D330050G23Rik
|
RIKEN cDNA D330050G23 gene |
chr16_-_23988852 | 0.74 |
ENSMUST00000023151.5
|
Bcl6
|
B cell leukemia/lymphoma 6 |
chr6_+_71272019 | 0.74 |
ENSMUST00000168700.1
|
Krcc1
|
lysine-rich coiled-coil 1 |
chr5_-_51567717 | 0.73 |
ENSMUST00000127135.1
ENSMUST00000151104.1 |
Ppargc1a
|
peroxisome proliferative activated receptor, gamma, coactivator 1 alpha |
chr10_-_68278713 | 0.73 |
ENSMUST00000020106.7
|
Arid5b
|
AT rich interactive domain 5B (MRF1-like) |
chr11_+_96024540 | 0.72 |
ENSMUST00000103157.3
|
Gip
|
gastric inhibitory polypeptide |
chr5_-_84417359 | 0.72 |
ENSMUST00000113401.1
|
Epha5
|
Eph receptor A5 |
chr2_-_126783416 | 0.72 |
ENSMUST00000130356.1
ENSMUST00000028842.2 |
Usp50
|
ubiquitin specific peptidase 50 |
chr3_-_85722474 | 0.71 |
ENSMUST00000119077.1
|
Fam160a1
|
family with sequence similarity 160, member A1 |
chr1_+_107361929 | 0.71 |
ENSMUST00000027566.2
|
Serpinb11
|
serine (or cysteine) peptidase inhibitor, clade B (ovalbumin), member 11 |
chr1_-_66945361 | 0.71 |
ENSMUST00000160100.1
|
Myl1
|
myosin, light polypeptide 1 |
chr19_+_8850785 | 0.70 |
ENSMUST00000096257.2
|
Lrrn4cl
|
LRRN4 C-terminal like |
chr19_-_12765447 | 0.69 |
ENSMUST00000112933.1
|
Cntf
|
ciliary neurotrophic factor |
chr2_-_164473714 | 0.69 |
ENSMUST00000017864.2
|
Trp53tg5
|
transformation related protein 53 target 5 |
chr15_-_81408261 | 0.68 |
ENSMUST00000057236.3
|
Dnajb7
|
DnaJ (Hsp40) homolog, subfamily B, member 7 |
chr7_+_119900099 | 0.68 |
ENSMUST00000106516.1
|
Lyrm1
|
LYR motif containing 1 |
chr9_+_21835506 | 0.68 |
ENSMUST00000058777.6
|
Gm6484
|
predicted gene 6484 |
chr5_-_83355120 | 0.67 |
ENSMUST00000053543.4
|
Tecrl
|
trans-2,3-enoyl-CoA reductase-like |
chr2_+_154162606 | 0.67 |
ENSMUST00000028986.2
|
Bpifa5
|
BPI fold containing family A, member 5 |
chr14_-_101640670 | 0.66 |
ENSMUST00000100339.2
|
Commd6
|
COMM domain containing 6 |
chrM_+_14138 | 0.66 |
ENSMUST00000082421.1
|
mt-Cytb
|
mitochondrially encoded cytochrome b |
chr16_-_89508313 | 0.66 |
ENSMUST00000056118.2
|
Krtap7-1
|
keratin associated protein 7-1 |
chr8_-_33747724 | 0.66 |
ENSMUST00000179364.1
|
Smim18
|
small integral membrane protein 18 |
chr8_+_45627709 | 0.66 |
ENSMUST00000134321.1
ENSMUST00000135336.1 |
Sorbs2
|
sorbin and SH3 domain containing 2 |
chr3_+_99253754 | 0.65 |
ENSMUST00000029462.5
|
Tbx15
|
T-box 15 |
chrM_-_14060 | 0.63 |
ENSMUST00000082419.1
|
mt-Nd6
|
mitochondrially encoded NADH dehydrogenase 6 |
chr10_-_5069044 | 0.63 |
ENSMUST00000095899.3
|
Syne1
|
spectrin repeat containing, nuclear envelope 1 |
chr1_-_63176653 | 0.63 |
ENSMUST00000027111.8
ENSMUST00000168099.2 |
Ndufs1
|
NADH dehydrogenase (ubiquinone) Fe-S protein 1 |
chr16_+_23107754 | 0.62 |
ENSMUST00000077605.5
ENSMUST00000115341.3 |
Eif4a2
|
eukaryotic translation initiation factor 4A2 |
chr16_+_23107413 | 0.62 |
ENSMUST00000023599.6
ENSMUST00000168891.1 |
Eif4a2
|
eukaryotic translation initiation factor 4A2 |
chr7_-_140900401 | 0.62 |
ENSMUST00000026561.8
|
Cox8b
|
cytochrome c oxidase subunit VIIIb |
chr7_-_139582790 | 0.61 |
ENSMUST00000106095.2
|
Nkx6-2
|
NK6 homeobox 2 |
chr2_-_166155624 | 0.61 |
ENSMUST00000109249.2
|
Sulf2
|
sulfatase 2 |
chr9_-_21067093 | 0.61 |
ENSMUST00000115494.2
|
Zglp1
|
zinc finger, GATA-like protein 1 |
chr10_+_96136603 | 0.61 |
ENSMUST00000074615.6
|
Gm5426
|
predicted pseudogene 5426 |
chr11_+_67200137 | 0.60 |
ENSMUST00000129018.1
|
Myh1
|
myosin, heavy polypeptide 1, skeletal muscle, adult |
chr17_-_34028044 | 0.60 |
ENSMUST00000045467.7
ENSMUST00000114303.3 |
H2-Ke6
|
H2-K region expressed gene 6 |
chr11_+_67078293 | 0.60 |
ENSMUST00000108689.1
ENSMUST00000165221.1 ENSMUST00000007301.7 |
Myh3
|
myosin, heavy polypeptide 3, skeletal muscle, embryonic |
chr6_-_97205549 | 0.60 |
ENSMUST00000164744.1
ENSMUST00000089287.5 |
Uba3
|
ubiquitin-like modifier activating enzyme 3 |
chr7_-_26686437 | 0.60 |
ENSMUST00000077356.6
|
Cyp2b23
|
cytochrome P450, family 2, subfamily b, polypeptide 23 |
chr1_-_66935333 | 0.59 |
ENSMUST00000120415.1
ENSMUST00000119429.1 |
Myl1
|
myosin, light polypeptide 1 |
chr2_+_85975213 | 0.59 |
ENSMUST00000082191.2
|
Olfr1029
|
olfactory receptor 1029 |
chr1_+_177445660 | 0.59 |
ENSMUST00000077225.6
|
Zbtb18
|
zinc finger and BTB domain containing 18 |
chr10_+_29211637 | 0.59 |
ENSMUST00000092627.4
|
9330159F19Rik
|
RIKEN cDNA 9330159F19 gene |
chrX_+_36195904 | 0.59 |
ENSMUST00000115258.2
|
Zcchc12
|
zinc finger, CCHC domain containing 12 |
chrX_-_72656135 | 0.58 |
ENSMUST00000055966.6
|
Gabra3
|
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 3 |
chr9_-_81633828 | 0.57 |
ENSMUST00000183482.1
|
Htr1b
|
5-hydroxytryptamine (serotonin) receptor 1B |
chrX_+_36195968 | 0.57 |
ENSMUST00000115256.1
|
Zcchc12
|
zinc finger, CCHC domain containing 12 |
chr1_-_191164815 | 0.56 |
ENSMUST00000171798.1
|
Fam71a
|
family with sequence similarity 71, member A |
chr4_-_14621805 | 0.56 |
ENSMUST00000042221.7
|
Slc26a7
|
solute carrier family 26, member 7 |
chr17_-_45592569 | 0.55 |
ENSMUST00000163492.1
|
Slc29a1
|
solute carrier family 29 (nucleoside transporters), member 1 |
chrX_+_103356464 | 0.55 |
ENSMUST00000116547.2
|
Chic1
|
cysteine-rich hydrophobic domain 1 |
chr1_-_170867761 | 0.55 |
ENSMUST00000027974.6
|
Atf6
|
activating transcription factor 6 |
chrX_+_36195950 | 0.55 |
ENSMUST00000115257.1
|
Zcchc12
|
zinc finger, CCHC domain containing 12 |
chr1_+_136624901 | 0.55 |
ENSMUST00000047734.8
ENSMUST00000112046.1 |
Zfp281
|
zinc finger protein 281 |
chr9_-_101198999 | 0.55 |
ENSMUST00000066773.7
|
Ppp2r3a
|
protein phosphatase 2, regulatory subunit B'', alpha |
chr11_-_119547744 | 0.55 |
ENSMUST00000026670.4
|
Nptx1
|
neuronal pentraxin 1 |
chr2_-_52558539 | 0.55 |
ENSMUST00000102760.3
ENSMUST00000102761.2 |
Cacnb4
|
calcium channel, voltage-dependent, beta 4 subunit |
chr4_-_109156610 | 0.55 |
ENSMUST00000161363.1
|
Osbpl9
|
oxysterol binding protein-like 9 |
chr4_-_14621669 | 0.54 |
ENSMUST00000143105.1
|
Slc26a7
|
solute carrier family 26, member 7 |
chr7_+_43712505 | 0.54 |
ENSMUST00000066834.6
|
Klk13
|
kallikrein related-peptidase 13 |
chr9_+_121950988 | 0.53 |
ENSMUST00000043011.7
|
Fam198a
|
family with sequence similarity 198, member A |
chr18_+_3382979 | 0.53 |
ENSMUST00000025073.5
|
Cul2
|
cullin 2 |
chrX_-_152327430 | 0.52 |
ENSMUST00000181635.1
ENSMUST00000141922.1 ENSMUST00000154085.1 ENSMUST00000148326.1 ENSMUST00000135115.1 ENSMUST00000149098.1 |
2900056M20Rik
|
RIKEN cDNA 2900056M20 gene |
chrX_+_36195938 | 0.52 |
ENSMUST00000048067.3
|
Zcchc12
|
zinc finger, CCHC domain containing 12 |
chr17_-_90088343 | 0.52 |
ENSMUST00000173917.1
|
Nrxn1
|
neurexin I |
chr6_-_144209471 | 0.51 |
ENSMUST00000038815.7
|
Sox5
|
SRY-box containing gene 5 |
chr5_-_116288944 | 0.51 |
ENSMUST00000086483.3
|
Ccdc60
|
coiled-coil domain containing 60 |
chr11_-_17211504 | 0.51 |
ENSMUST00000020317.7
|
Pno1
|
partner of NOB1 homolog (S. cerevisiae) |
chr6_+_97807014 | 0.51 |
ENSMUST00000043637.7
|
Mitf
|
microphthalmia-associated transcription factor |
chrX_+_10717390 | 0.51 |
ENSMUST00000115524.1
ENSMUST00000008179.6 |
Mid1ip1
|
Mid1 interacting protein 1 (gastrulation specific G12-like (zebrafish)) |
chr3_+_129836729 | 0.50 |
ENSMUST00000077918.5
|
Cfi
|
complement component factor i |
chr10_-_56228636 | 0.50 |
ENSMUST00000099739.3
|
Tbc1d32
|
TBC1 domain family, member 32 |
chr14_-_48667508 | 0.50 |
ENSMUST00000144465.1
ENSMUST00000133479.1 ENSMUST00000119070.1 ENSMUST00000152018.1 |
Otx2
|
orthodenticle homolog 2 (Drosophila) |
chrX_+_141475385 | 0.50 |
ENSMUST00000112931.1
ENSMUST00000112930.1 |
Col4a5
|
collagen, type IV, alpha 5 |
chr5_-_23844085 | 0.49 |
ENSMUST00000030851.6
|
Tomm7
|
translocase of outer mitochondrial membrane 7 homolog (yeast) |
chrM_+_5319 | 0.49 |
ENSMUST00000082402.1
|
mt-Co1
|
mitochondrially encoded cytochrome c oxidase I |
chr4_+_11579647 | 0.49 |
ENSMUST00000180239.1
|
Fsbp
|
fibrinogen silencer binding protein |
chr16_+_56477838 | 0.49 |
ENSMUST00000048471.7
ENSMUST00000096013.3 ENSMUST00000096012.3 ENSMUST00000171000.1 |
Abi3bp
|
ABI gene family, member 3 (NESH) binding protein |
chr4_+_99030946 | 0.49 |
ENSMUST00000030280.6
|
Angptl3
|
angiopoietin-like 3 |
chr6_-_144209448 | 0.48 |
ENSMUST00000077160.5
|
Sox5
|
SRY-box containing gene 5 |
chrX_+_140456613 | 0.48 |
ENSMUST00000033809.3
|
Prps1
|
phosphoribosyl pyrophosphate synthetase 1 |
chr11_-_53634698 | 0.48 |
ENSMUST00000020650.1
|
Il13
|
interleukin 13 |
chr1_-_138842429 | 0.48 |
ENSMUST00000112026.2
ENSMUST00000019374.7 |
Lhx9
|
LIM homeobox protein 9 |
chr2_+_90987603 | 0.48 |
ENSMUST00000111452.1
ENSMUST00000111455.2 |
Celf1
|
CUGBP, Elav-like family member 1 |
chr3_-_92123943 | 0.48 |
ENSMUST00000070284.3
|
Prr9
|
proline rich 9 |
chr14_+_47663756 | 0.48 |
ENSMUST00000022391.7
|
Ktn1
|
kinectin 1 |
chr6_+_134035691 | 0.47 |
ENSMUST00000081028.6
ENSMUST00000111963.1 |
Etv6
|
ets variant gene 6 (TEL oncogene) |
chr13_-_23698454 | 0.47 |
ENSMUST00000102967.1
|
Hist1h4c
|
histone cluster 1, H4c |
chr4_+_88850087 | 0.47 |
ENSMUST00000094972.1
|
Ifna1
|
interferon alpha 1 |
chr8_+_129118043 | 0.47 |
ENSMUST00000108744.1
|
1700008F21Rik
|
RIKEN cDNA 1700008F21 gene |
chr10_-_103028771 | 0.47 |
ENSMUST00000040859.5
|
Alx1
|
ALX homeobox 1 |
chr2_-_103303158 | 0.47 |
ENSMUST00000111176.2
|
Ehf
|
ets homologous factor |
chr13_-_85127514 | 0.47 |
ENSMUST00000179230.1
|
Gm4076
|
predicted gene 4076 |
chr5_+_105824511 | 0.46 |
ENSMUST00000055994.3
|
D830014E11Rik
|
RIKEN cDNA D830014E11 gene |
chr7_-_30729505 | 0.46 |
ENSMUST00000006478.8
|
Tmem147
|
transmembrane protein 147 |
chr7_-_90475971 | 0.46 |
ENSMUST00000032843.7
|
Tmem126b
|
transmembrane protein 126B |
chr2_+_83955693 | 0.46 |
ENSMUST00000179192.1
|
Gm13698
|
predicted gene 13698 |
chr8_-_41054771 | 0.45 |
ENSMUST00000093534.4
|
Mtus1
|
mitochondrial tumor suppressor 1 |
chr10_+_5069192 | 0.45 |
ENSMUST00000180100.1
|
Gm10097
|
predicted gene 10097 |
chr9_-_89738414 | 0.45 |
ENSMUST00000060700.1
|
Ankrd34c
|
ankyrin repeat domain 34C |
chr17_-_45592485 | 0.45 |
ENSMUST00000166119.1
|
Slc29a1
|
solute carrier family 29 (nucleoside transporters), member 1 |
chr3_+_103914099 | 0.45 |
ENSMUST00000051139.6
ENSMUST00000068879.4 |
Rsbn1
|
rosbin, round spermatid basic protein 1 |
chr13_+_22035821 | 0.45 |
ENSMUST00000110455.2
|
Hist1h2bk
|
histone cluster 1, H2bk |
chr7_-_92669917 | 0.45 |
ENSMUST00000119954.1
|
Pcf11
|
cleavage and polyadenylation factor subunit homolog (S. cerevisiae) |
chr6_-_144209558 | 0.45 |
ENSMUST00000111749.1
ENSMUST00000170367.2 |
Sox5
|
SRY-box containing gene 5 |
chr2_-_48949206 | 0.44 |
ENSMUST00000090976.3
ENSMUST00000149679.1 ENSMUST00000028098.4 |
Orc4
|
origin recognition complex, subunit 4 |
chr11_+_97685903 | 0.43 |
ENSMUST00000107583.2
|
Cisd3
|
CDGSH iron sulfur domain 3 |
chr3_+_92957386 | 0.43 |
ENSMUST00000059053.9
|
Lce3d
|
late cornified envelope 3D |
chr2_-_157346647 | 0.43 |
ENSMUST00000029172.1
|
Ghrh
|
growth hormone releasing hormone |
chr10_-_88605017 | 0.43 |
ENSMUST00000119185.1
ENSMUST00000121629.1 |
Mybpc1
|
myosin binding protein C, slow-type |
chr7_+_62476306 | 0.43 |
ENSMUST00000097132.3
|
Atp5l-ps1
|
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit g, pseudogene 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 7.9 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.8 | 3.3 | GO:0034760 | negative regulation of iron ion transport(GO:0034757) negative regulation of iron ion transmembrane transport(GO:0034760) |
0.6 | 2.3 | GO:0010986 | regulation of high-density lipoprotein particle clearance(GO:0010982) positive regulation of lipoprotein particle clearance(GO:0010986) |
0.4 | 2.2 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.4 | 14.1 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.4 | 1.3 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
0.4 | 1.5 | GO:0090126 | protein complex assembly involved in synapse maturation(GO:0090126) |
0.4 | 2.2 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.4 | 0.7 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.3 | 1.0 | GO:0006713 | glucocorticoid catabolic process(GO:0006713) |
0.3 | 1.0 | GO:0061193 | taste bud development(GO:0061193) |
0.3 | 0.8 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.2 | 2.1 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) |
0.2 | 1.1 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.2 | 3.8 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
0.2 | 1.4 | GO:0015862 | uridine transport(GO:0015862) |
0.2 | 0.4 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
0.2 | 0.9 | GO:0048690 | regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
0.2 | 0.7 | GO:0048294 | regulation of memory T cell differentiation(GO:0043380) negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.2 | 0.7 | GO:2000182 | regulation of progesterone biosynthetic process(GO:2000182) |
0.2 | 1.4 | GO:0019532 | oxalate transport(GO:0019532) |
0.2 | 0.3 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
0.2 | 1.0 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.2 | 0.5 | GO:0072343 | pancreatic stellate cell proliferation(GO:0072343) regulation of pancreatic stellate cell proliferation(GO:2000229) |
0.2 | 0.5 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.2 | 0.5 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.2 | 0.3 | GO:0070948 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.1 | 0.6 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
0.1 | 1.3 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.1 | 0.4 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.1 | 1.7 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 0.4 | GO:0007493 | endodermal cell fate determination(GO:0007493) |
0.1 | 0.5 | GO:0007525 | somatic muscle development(GO:0007525) |
0.1 | 2.2 | GO:0030299 | intestinal cholesterol absorption(GO:0030299) |
0.1 | 0.9 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.1 | 1.8 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) |
0.1 | 1.9 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.1 | 1.1 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.1 | 1.9 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.1 | 0.5 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.1 | 1.3 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.1 | 0.7 | GO:0033762 | response to glucagon(GO:0033762) |
0.1 | 0.3 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.1 | 1.1 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.1 | 0.4 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.1 | 0.6 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.1 | 1.1 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.1 | 0.3 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
0.1 | 0.4 | GO:0031161 | phosphatidylinositol catabolic process(GO:0031161) |
0.1 | 0.3 | GO:1900248 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
0.1 | 0.5 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.1 | 0.6 | GO:0014063 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) negative regulation of serotonin secretion(GO:0014063) cellular response to temperature stimulus(GO:0071502) |
0.1 | 0.2 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.1 | 0.4 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.1 | 1.6 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.1 | 0.5 | GO:0035865 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.1 | 1.1 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 0.9 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.1 | 0.8 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.1 | 0.3 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.1 | 0.2 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.1 | 0.5 | GO:0042706 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.1 | 1.1 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.9 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.1 | 0.4 | GO:1903860 | negative regulation of dendrite extension(GO:1903860) |
0.1 | 3.7 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.1 | 0.7 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.1 | 0.4 | GO:0097476 | spinal cord motor neuron migration(GO:0097476) |
0.1 | 0.3 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.1 | 0.8 | GO:0007320 | insemination(GO:0007320) |
0.1 | 0.4 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.1 | 1.3 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.1 | 0.2 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.1 | 0.8 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.1 | 0.1 | GO:0001546 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.1 | 1.3 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.1 | 0.5 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.1 | 0.4 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.1 | 0.2 | GO:0031660 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) |
0.1 | 0.4 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.1 | 0.4 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.1 | 0.8 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 0.3 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.1 | 0.3 | GO:0009624 | response to nematode(GO:0009624) |
0.1 | 0.5 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.1 | 0.2 | GO:0032962 | positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
0.1 | 0.3 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.1 | 0.5 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.1 | 0.5 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.1 | 0.4 | GO:0007296 | vitellogenesis(GO:0007296) |
0.1 | 0.2 | GO:0097401 | synaptic vesicle lumen acidification(GO:0097401) |
0.1 | 0.1 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.1 | 0.2 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.1 | 0.3 | GO:0097475 | motor neuron migration(GO:0097475) |
0.1 | 0.3 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.1 | 1.8 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.1 | 0.4 | GO:0070294 | renal sodium ion absorption(GO:0070294) regulation of inward rectifier potassium channel activity(GO:1901979) |
0.0 | 0.5 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.0 | 0.0 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
0.0 | 0.3 | GO:0060023 | soft palate development(GO:0060023) |
0.0 | 0.2 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.0 | 1.3 | GO:0014823 | response to activity(GO:0014823) |
0.0 | 0.5 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.0 | 1.2 | GO:0040023 | nuclear migration(GO:0007097) establishment of nucleus localization(GO:0040023) |
0.0 | 0.4 | GO:0046010 | positive regulation of circadian sleep/wake cycle, non-REM sleep(GO:0046010) |
0.0 | 0.4 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.0 | 0.1 | GO:0009732 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.0 | 0.2 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.0 | 0.4 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) |
0.0 | 0.2 | GO:0014891 | skeletal muscle atrophy(GO:0014732) striated muscle atrophy(GO:0014891) |
0.0 | 0.5 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.0 | 0.4 | GO:1904714 | Golgi disassembly(GO:0090166) regulation of chaperone-mediated autophagy(GO:1904714) |
0.0 | 1.4 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.0 | 0.7 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 1.1 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.0 | 1.8 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.0 | 0.1 | GO:0070342 | brown fat cell proliferation(GO:0070342) regulation of brown fat cell proliferation(GO:0070347) |
0.0 | 0.3 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.0 | 0.9 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.0 | 0.8 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.0 | 0.2 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
0.0 | 0.2 | GO:2000292 | negative regulation of eating behavior(GO:1903999) regulation of defecation(GO:2000292) negative regulation of defecation(GO:2000293) |
0.0 | 0.4 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.0 | 1.0 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.0 | 0.2 | GO:0060005 | vestibular reflex(GO:0060005) |
0.0 | 0.2 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.0 | 1.4 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.0 | 1.7 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.0 | 0.4 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.2 | GO:0061056 | somite specification(GO:0001757) sclerotome development(GO:0061056) |
0.0 | 0.2 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.0 | 0.2 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.0 | 0.2 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.0 | 0.1 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.0 | 0.3 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.0 | 0.1 | GO:0097283 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.0 | 0.6 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.2 | GO:0050957 | equilibrioception(GO:0050957) |
0.0 | 0.2 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.0 | 0.8 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 | 0.4 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) |
0.0 | 0.1 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
0.0 | 0.2 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.0 | 0.5 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.0 | 0.2 | GO:0045842 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.0 | 1.9 | GO:0030500 | regulation of bone mineralization(GO:0030500) |
0.0 | 0.0 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.0 | 0.4 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.0 | 0.5 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.0 | 0.6 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.0 | 0.5 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.0 | 2.4 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.1 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
0.0 | 0.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.0 | 0.0 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.0 | 0.8 | GO:0042773 | ATP synthesis coupled electron transport(GO:0042773) |
0.0 | 0.1 | GO:0070859 | positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
0.0 | 0.2 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) cellular response to zinc ion(GO:0071294) |
0.0 | 0.9 | GO:0060325 | face morphogenesis(GO:0060325) |
0.0 | 0.4 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.0 | 0.4 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.0 | 0.3 | GO:0022010 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.0 | 0.3 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.0 | 0.9 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.0 | 1.9 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.0 | 0.1 | GO:0031000 | response to caffeine(GO:0031000) |
0.0 | 3.1 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.6 | GO:0048599 | oocyte development(GO:0048599) |
0.0 | 0.2 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.0 | 0.3 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.0 | 0.2 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.0 | 0.0 | GO:0034372 | triglyceride-rich lipoprotein particle remodeling(GO:0034370) very-low-density lipoprotein particle remodeling(GO:0034372) chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.0 | 0.1 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.0 | 0.0 | GO:0061517 | macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) |
0.0 | 0.5 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.0 | 0.0 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.0 | 0.1 | GO:0061314 | ciliary body morphogenesis(GO:0061073) pulmonary artery morphogenesis(GO:0061156) Notch signaling involved in heart development(GO:0061314) |
0.0 | 0.6 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.1 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.0 | 0.1 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.0 | 0.2 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.0 | 1.2 | GO:0009166 | nucleotide catabolic process(GO:0009166) |
0.0 | 0.4 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.0 | 0.3 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.0 | 0.1 | GO:0014029 | neural crest formation(GO:0014029) |
0.0 | 0.4 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.0 | 0.1 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.0 | 0.2 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.0 | 0.8 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.0 | 0.2 | GO:0006744 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) |
0.0 | 1.5 | GO:0098656 | anion transmembrane transport(GO:0098656) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 2.1 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) |
0.2 | 0.7 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.1 | 0.5 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.1 | 0.4 | GO:0070552 | BRISC complex(GO:0070552) |
0.1 | 0.5 | GO:0030891 | VCB complex(GO:0030891) |
0.1 | 3.8 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 2.8 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 0.3 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.1 | 0.4 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.1 | 1.5 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 0.5 | GO:0098645 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.1 | 0.7 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.1 | 1.5 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.2 | GO:0072534 | perineuronal net(GO:0072534) |
0.1 | 1.7 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 0.4 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.1 | 0.2 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.1 | 0.5 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 0.6 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.1 | 0.4 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.1 | 0.8 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 1.6 | GO:0032982 | myosin filament(GO:0032982) |
0.1 | 1.1 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 0.7 | GO:0045275 | respiratory chain complex III(GO:0045275) |
0.1 | 0.8 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.1 | 0.3 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.1 | 1.0 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 0.4 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 0.4 | GO:0001652 | granular component(GO:0001652) |
0.1 | 0.6 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 0.2 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 0.3 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.0 | 0.5 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.0 | 1.4 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 1.8 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.0 | 0.6 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.0 | 7.3 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 2.1 | GO:0043034 | costamere(GO:0043034) |
0.0 | 0.4 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.0 | 0.8 | GO:0071564 | npBAF complex(GO:0071564) |
0.0 | 0.8 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.0 | 0.5 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 0.5 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 0.3 | GO:0036156 | inner dynein arm(GO:0036156) |
0.0 | 0.2 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 1.0 | GO:0097440 | apical dendrite(GO:0097440) |
0.0 | 0.2 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.0 | 2.0 | GO:0000502 | proteasome complex(GO:0000502) |
0.0 | 1.3 | GO:0070469 | respiratory chain(GO:0070469) |
0.0 | 0.2 | GO:0036128 | CatSper complex(GO:0036128) |
0.0 | 0.2 | GO:0030478 | actin cap(GO:0030478) |
0.0 | 0.8 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 0.1 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.0 | 0.0 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.0 | 1.8 | GO:0043195 | terminal bouton(GO:0043195) |
0.0 | 0.4 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.0 | 0.2 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.0 | 0.3 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.6 | GO:0000786 | nucleosome(GO:0000786) |
0.0 | 1.1 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 0.2 | GO:0042581 | specific granule(GO:0042581) |
0.0 | 4.8 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.0 | 0.9 | GO:0005657 | replication fork(GO:0005657) |
0.0 | 0.6 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 0.8 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.2 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 1.2 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 0.2 | GO:0035102 | PRC1 complex(GO:0035102) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 7.9 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
1.7 | 10.1 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
1.2 | 3.5 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
1.2 | 4.6 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.4 | 2.4 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.4 | 1.1 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
0.3 | 1.0 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.3 | 2.2 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.3 | 1.3 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.3 | 1.5 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.2 | 1.9 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
0.2 | 1.1 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.2 | 1.1 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.2 | 2.6 | GO:0016151 | nickel cation binding(GO:0016151) |
0.2 | 2.3 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.2 | 4.5 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.2 | 1.1 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.2 | 1.6 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.2 | 1.1 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.1 | 0.4 | GO:0016608 | growth hormone-releasing hormone activity(GO:0016608) |
0.1 | 2.2 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 0.4 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.1 | 1.8 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.1 | 0.5 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.1 | 0.6 | GO:0070404 | NADH binding(GO:0070404) |
0.1 | 1.5 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.1 | 0.9 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.1 | 0.3 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.1 | 0.5 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.1 | 0.7 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 0.9 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 0.3 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.1 | 0.7 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 0.2 | GO:0036132 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
0.1 | 1.4 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.1 | 0.8 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.1 | 0.4 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 0.8 | GO:0034046 | poly(G) binding(GO:0034046) |
0.1 | 0.2 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.1 | 0.9 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 0.5 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.1 | 0.4 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.1 | 2.5 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.1 | 0.4 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.1 | 1.9 | GO:0032183 | SUMO binding(GO:0032183) |
0.1 | 0.2 | GO:0031531 | thyrotropin-releasing hormone receptor binding(GO:0031531) |
0.1 | 0.2 | GO:0008431 | vitamin E binding(GO:0008431) |
0.1 | 1.4 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.7 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.1 | 0.2 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
0.1 | 1.5 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.1 | 0.2 | GO:0034188 | apolipoprotein receptor activity(GO:0030226) apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
0.0 | 0.4 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 0.6 | GO:0051378 | serotonin binding(GO:0051378) |
0.0 | 0.5 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.0 | 0.6 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.0 | 0.5 | GO:0015266 | protein channel activity(GO:0015266) |
0.0 | 0.1 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
0.0 | 0.5 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.0 | 0.4 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 0.2 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.0 | 0.7 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.2 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
0.0 | 1.1 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 1.1 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.0 | 0.2 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.0 | 0.3 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.0 | 0.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 3.2 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.4 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.2 | GO:1904315 | GABA-gated chloride ion channel activity(GO:0022851) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
0.0 | 0.6 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 0.7 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 0.6 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.2 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.0 | 2.6 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.0 | 0.6 | GO:0030955 | potassium ion binding(GO:0030955) |
0.0 | 0.2 | GO:0016934 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.0 | 1.7 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.0 | 1.0 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.2 | GO:0032564 | dATP binding(GO:0032564) |
0.0 | 0.1 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.0 | 0.3 | GO:0019841 | retinol binding(GO:0019841) |
0.0 | 0.7 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 0.6 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.2 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.0 | 0.3 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.3 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.0 | 0.6 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.0 | 0.2 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.0 | 0.3 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 1.4 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 1.0 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.0 | 0.3 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.0 | 0.1 | GO:0004356 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) |
0.0 | 0.3 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 1.0 | GO:0008374 | O-acyltransferase activity(GO:0008374) |
0.0 | 0.2 | GO:0048185 | activin binding(GO:0048185) |
0.0 | 0.5 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.0 | 3.1 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.2 | GO:0051861 | glycolipid binding(GO:0051861) |
0.0 | 1.6 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.4 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.4 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.0 | 0.1 | GO:0071253 | connexin binding(GO:0071253) |
0.0 | 0.6 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 0.2 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 1.1 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.0 | 1.4 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.4 | GO:0005310 | dicarboxylic acid transmembrane transporter activity(GO:0005310) |
0.0 | 0.2 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.0 | 0.8 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.3 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.0 | 0.2 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.0 | 0.4 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.0 | 0.5 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.0 | 0.6 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.1 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.0 | 0.0 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.0 | 0.7 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.0 | 0.4 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.3 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.0 | 0.1 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.0 | 0.4 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 0.3 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 1.0 | GO:0101005 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.5 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 1.7 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 1.2 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.6 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 1.8 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 3.3 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 4.0 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 1.4 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 0.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.9 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.7 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.4 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.7 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 0.7 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.9 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 1.3 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.1 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 0.7 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.7 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 0.6 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 0.5 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.2 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.5 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.3 | PID EPHA FWDPATHWAY | EPHA forward signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 2.2 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.2 | 1.7 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 1.9 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 0.3 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.1 | 1.7 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 1.2 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 2.9 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.1 | 0.9 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 0.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 1.0 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 1.1 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 0.9 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.1 | 0.6 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 0.3 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 1.0 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.2 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.0 | 0.4 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.0 | 2.8 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.0 | 3.0 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.0 | 1.2 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.7 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.0 | 0.5 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 1.6 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.9 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 1.4 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.6 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.0 | 0.9 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 0.4 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.0 | 0.7 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.5 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.4 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.0 | 0.4 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.0 | 1.4 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.4 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 0.2 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.0 | 0.2 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.8 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.0 | 0.2 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.2 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 0.8 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 0.2 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |